WEB EXCLUSIVE
By Laura Ernde
Daily Journal Staff Writer
SACRAMENTO - The California Supreme Court on Tuesday appeared sympathetic to a biotech company's arguments for why it should get out of paying part of a $500 million jury verdict.
Six years ago, a Los Angeles jury found that Genentech cheated a nonprofit cancer research hospital out of $300 million in royalties for using its...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In